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Dysregulation of autophagy in the 
central nervous system of sheep 
naturally infected with classical 
scrapie
Óscar López-pérez1,2, Alicia otero2, Hicham Filali  2, David sanz-Rubio1, Janne M. toivonen1, 
pilar Zaragoza1, Juan J. Badiola2, Rosa Bolea2 & Inmaculada Martín-Burriel  1,2
Autophagy is a dynamic cellular mechanism involved in protein and organelle turnover through 
lysosomal degradation. Autophagy regulation modulates the pathologies associated with many 
neurodegenerative diseases. Using sheep naturally infected with scrapie as a natural animal model of 
prion diseases, we investigated the regulation of autophagy in the central nervous system (CNS) during 
the clinical phase of the disease. We present a gene expression and protein distribution analysis of 
different autophagy-related markers and investigate their relationship with prion-associated lesions in 
several areas of the CNS. Gene expression of autophagy markers ATG5 and ATG9 was downregulated 
in some areas of scrapie brains. In contrast, ATG5 protein accumulates in medulla oblongata and 
positively correlates with prion deposition and scrapie-related lesions. The accumulation of this protein 
and p62, a marker of autophagy impairment, suggests that autophagy is decreased in the late phases 
of the disease. However, the increment of LC3 proteins and the mild expression of p62 in basal ganglia 
and cerebellum, primarily in Purkinje cells, suggests that autophagy machinery is still intact in less 
affected areas. We hypothesize that specific cell populations of the CNS may display neuroprotective 
mechanisms against prion-induced toxicity through the induction of PrPsc clearance by autophagy.
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a group of fatal neurodegenerative 
disorders that can affect humans and animals1. TSEs include kuru, Creutzfeldt-Jakob disease (CJD) and its vari-
ant, Gerstmann-Sträussler-Scheinker (GSS) disease, and fatal familial insomnia in humans, bovine spongiform 
encephalopathy in cattle, and scrapie in sheep and goats2. Scrapie was the first TSE known and can be considered 
a good natural animal model to study the neuropathological mechanisms of these diseases3.
Prion diseases are characterized by a rapidly progressing course that leads inevitably to death, usually within 
a few months. According to the protein-only hypothesis4, TSEs are caused by the conversion of the normal 
mammalian cellular prion protein (PrPc) into its pathological conformation, or scrapie-associated prion pro-
tein (PrPSc), which is abnormally folded, β-sheet enriched and partially protease resistant. Hence, prion dis-
eases share profound similarities with other protein misfolding and neurodegenerative diseases like Alzheimer’s, 
Huntington’s and Parkinson’s disease5. The accumulation of PrPSc in the central nervous system (CNS) induces 
neuronal degeneration, vacuolation of the neuronal cell bodies (intraneuronal vacuolation) and neuropil (spong-
iosis), glial cell activation and neuronal loss by cellular death6.
Although several mechanisms have been proposed to explain neuronal death in prion diseases, apoptosis and 
autophagy are the types of cell death considered most likely to be involved7. Studies on the molecular mechanisms 
underlying neuronal apoptosis in brains of ovine naturally infected with scrapie have shown that, besides the 
upregulation of the pro-apoptotic protein BAX (BCL2 Associated X, Apoptosis Regulator) and its correlation with 
neuropathological features of scrapie, this process appears to be blocked somehow, or it is present at extremely 
low levels8,9. Apoptosis arrest could be a consequence of the activation of neuroprotective pathways that counter-
act massive cell death.
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Autophagy is a fundamental cellular process involved in the turnover of long-lived proteins, protein com-
plexes, cytoplasmic constituents and whole organelles through lysosomal degradation, in response to external 
and internal triggers. One of the primary roles of autophagy is to respond to nutrient starvation by produc-
ing amino acids10. Besides this fundamental role, autophagy contributes to other physiological processes such 
as intracellular clearance, differentiation, organismal development and elimination of invading pathogens10,11. 
Paradoxically, despite these pro-survival functions, autophagy can also mediate a non-apoptotic cell death, also 
called autophagic cell death12. When properly regulated, autophagy supports normal cellular and developmental 
processes, whereas autophagic dysfunction is associated with several pathologies, including neurodegenerative 
disorders13. It is still difficult to decipher whether active autophagy in the degenerating neurons plays a protective 
role, contributes to pathogenic neuronal death, or both.
Autophagy seems to be the main route of PrPSc degradation14 and autophagic vacuoles have been described in 
experimental models of prion diseases, in induced scrapie and in the natural disease in humans7,15–17. During the 
last decade, the role of autophagy in prion diseases has been investigated in induced murine models of prion dis-
eases18–21, and new treatments for prion diseases based on the activation of the autophagic flux have been tested 
in cell culture22–25. However, the biological role of autophagy in the natural disease, or even the relationship of 
this process with prion-related pathology, are still poorly understood. Investigating this process in natural mod-
els such as ovine scrapie could possibly help in understanding the role of autophagy in human prion diseases, as 
studies on human brain samples are very few and generally suffer from small number of replicates20.
Autophagy requires activity of numerous proteins involved in distinct steps of this degradative route26. Among 
these, ATGs (Autophagy-Related proteins), MAP1-LC3s (Microtubule-Associated Protein 1 Light Chain 3 pro-
teins, hereafter referred to as LC3) and p62/SQSTM1 (sequestosome 1) have been previously analysed in detail 
in different neurodegenerative diseases. The aim of this study was to analyse the regulation of autophagy in the 
CNS of sheep naturally infected with scrapie in a clinical phase. Through the combination of gene expression and 
immunohistochemical analysis of autophagy markers, the relationship between autophagy induction and prion 
pathology is presented, showing clear regional differences in autophagy regulation in response to the disease.
Results
Scrapie-associated neuropathology corresponds to the classical form of the disease. Prior to 
the analysis of autophagy, the clinical diagnosis of selected sheep was confirmed and the distribution of prion 
related histopathological lesions was determined. Neuropil spongiosis, intraneuronal vacuolation and PrPSc dep-
osition were evaluated semi-quantitatively in eight brain regions: frontal cortex (Fc), basal ganglia (Bg), basal 
ganglia cortex (Bgc), thalamic cortex (Tc), thalamus (T), pons (P), cerebellum (Cbl) and medulla oblongata (Mo). 
In addition, five neuronal nuclei of the Mo were also studied: the hypoglossal motor nucleus (HMN), the dorsal 
nucleus of the vagus nerve (NVN), the lateral cuneate nucleus (LCN), the nucleus of the trigeminal nerve spinal 
tract (NTN) and the olivary nucleus (ON).
The pattern of the lesions was analysed in six controls and six clinical, scrapie-infected sheep (Supplementary 
Figs S1 and S2). Despite the fact that high variability was observed for all lesions within the scrapie group, statisti-
cally significant differences (P < 0.05) were detected between scrapie animals and the control group in most cases. 
The evaluation of haematoxylin-eosin-stained sections revealed a significant and strong increase of spongiosis 
and neuronal vacuolation in the T, P and Mo of the infected animals compared with controls. PrPSc immunolabel-
ling confirmed the diagnosis of scrapie in sheep that presented neurological symptoms. Intraneuronal and neu-
ropil PrPSc deposition was detected only in the affected animals. PrPSc immunolabelling was significantly strong 
in P, T and Mo, moderate in Cbl and Fc, and weak in Bg, Bgc and Tc. In Mo, the NVN displayed the highest scores 
for PrPSc deposition and for the other studied lesions. As expected, scrapie-related lesions positively correlated 
with each other (Supplementary Table S1). The observed lesion pattern corresponds to the one described for the 
classical form of scrapie27.
mRNA expression of two autophagy markers, ATG5 and ATG9, is downregulated in scrapie brains. 
To investigate the regulation of the autophagy process in scrapie animals, expression of four genes (ATG5, BECN1, 
ATG9 and LC3-B) involved in distinct steps of autophagy were quantified in Fc, T, Cbl and Mo of scrapie-infected 
sheep and healthy controls by quantitative real-time PCR (qRT-PCR). As shown in Fig. 1, gene expression profiles 
were different in each analysed area and generally few alterations were found. However, a significant downregulation 
was observed for ATG5 (P < 0.05) in T and ATG9 (P < 0.01) in Cbl of scrapie-infected animals.
Expression of ATG5 and BECN1 is negatively correlated with prion deposition in thalamus of scrapie 
animals. To distinguish any relationship between the degree of lesion and the level of transcripts for autophagy 
markers, non-parametric Spearman’s rank correlation coefficients (rho, ρ) were calculated between expression lev-
els and the scores for PrPSc deposition, neuronal vacuolation and neuropil spongiosis in the four analysed areas. 
Significant correlations found were mostly related with gene expression changes observed between scrapie and con-
trol animals (Supplementary Table S2) and significance was lost when scrapie sheep only were analysed. However, 
the strong negative correlation observed between ATG5 and prion deposition in thalamus in the total set of individ-
uals (ρ = −0.739, P < 0.01) was maintained in scrapie tissues (ρ = −0.833, P < 0.05). BECN1 expression levels also 
correlated negatively (ρ = −0.833, P < 0.05) with PrPSc deposition in this tissue in scrapie sheep.
Accumulation of ATG5 protein in medulla oblongata of scrapie sheep. To evaluate if the 
transcript-level alterations were also observed in ATG5 protein levels, distribution of this marker was determined 
by immunohistochemistry (IHC) in eight areas of the CNS (Fc, Bg, Bgc, Tc, T, P, Cbl and Mo) in scrapie and con-
trol sheep. A distinctive band of ~32 kDa confirmed the specificity of the antibody used in Western blot analysis 
(Supplementary Fig. S3). In contrast to the transcript levels, ATG5 protein was significantly increased in the Mo 
www.nature.com/scientificreports/
3Scientific RepoRts |          (2019) 9:1911  | https://doi.org/10.1038/s41598-019-38500-2
of scrapie infected animals (P = 0.029), and specifically in the NTN (P = 0.028) (Fig. 2A,B). Accordingly, ATG5 
mRNA and protein expression displayed a significant negative correlation (Spearman ρ = −0.420, P = 0.003). 
ATG5 immunostaining presented an intracytoplasmic and a punctiform pattern in the neuropil in several 
regions, such as the T, Cbl, P and Mo (Fig. 3). In these areas, ATG5 protein was occasionally stained as a diffuse 
spot throughout the neuropil, and in granules within the cytoplasm of some neurons. These granules usually 
displayed a perineuronal arrangement.
LC3-B is overexpressed in scrapie cerebella and basal ganglia. IHC allows the determination of 
small changes that could go unnoticed in gene expression analysis where mRNAs come from the different cells 
present in a tissue. Then, although gene expression of LC3-B was not modified in scrapie tissues, we next analysed 
the protein distribution of LC3-B by IHC. Specificity of the antibody used was tested by Western blot that revealed 
a single ~15 kDa band (Supplementary Fig. S3). The semi-quantitative analysis of LC3-B immunostaining showed 
statistically significant increase in Bg (P = 0.02) and in Cbl (P = 0.04) of scrapie-infected animals (Fig. 2C,D). This 
increment was confirmed comparing Cbl lysates by immunoblot. Scrapie cerebella displayed a trend (P = 0.09) to 
LC3-B upregulation (Supplementary Fig. S4). We did not detect LC3-II bands in the immunoblot, probably due 
to the dilution of signal of autophagy cells in the whole tissue. There were no significant alterations in the other 
tissues under study. As opposed to ATG5, LC3-B levels were not modified in the neuronal nuclei of the Mo of 
scrapie-infected animals and LC3-B protein levels did not correlate with those of its transcript (data not shown). 
Generally, LC3-B immunostaining consisted of a mild diffuse and punctiform neuropil staining (Fig. 4). In addi-
tion, neuronal cytoplasm and nuclei were generally stained positively. Even neurons with unstained cytoplasm 
often displayed nuclear positive immunolabelling.
LC3-A is upregulated in specific neuronal populations of scrapie CNS. Although LC3-A was not 
analysed at the transcript level, we studied the distribution of this protein to analyse if different LC3s proteins 
react similarly in response to scrapie. As with the other markers, the specificity of antibody was confirmed by 
Western blot, displaying a band of ~15/18 kDa (Supplementary Fig. S3). In this case, LC3-A protein staining was 
more intense in P (P = 0.03), Cbl (P = 0.032) and HMN (expressed only in scrapie animals and not in controls) 
of scrapie animals (Fig. 2E,F). These differences were mainly due to an increase in the immunostaining of specific 
neural populations. Whereas LC3-A staining was mainly observed in the neuropil in control animals, intense 
neuronal immunolabelling was detected in P, Cbl and the HMN of scrapie sheep (Fig. 5). In these areas, both 
Figure 1. mRNA expression profiles of the ATG5, BECN1, ATG9 and LC3-B autophagy-related genes. Relative 
expression levels in control (black bars) and scrapie-infected sheep (grey bars) in the frontal cortex (Fc), 
thalamus (T), cerebellum (Cbl) and medulla oblongata (Mo) are expressed as mean ± standard deviation. 
Results were normalized using the geometric mean of the expression of three housekeeping genes (GAPDH, 
G6PDH and RPL32). The expression values were log transformed to analyse the differences between the two 
experimental groups using the Student’s t-test (*P < 0.05 and **P < 0.01).
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Figure 2. Semi-quantitative scoring of immunohistology for autophagy-related proteins. Score values of ATG5 
(A,B), LC3-B (C,D), LC3-A (E,F) and p62 (G,H) (from 0: negative, to 5: staining present at its maximum 
intensity) evaluated in frontal cortex (Fc), basal ganglia (Bg), basal ganglia cortex (Bgc), thalamic cortex 
(Tc), thalamus (T), pons (P), cerebellum (Cbl) and five neuronal nuclei of the medulla oblongata (Mo): the 
hypoglossal motor nucleus (HMN), the dorsal nucleus of the vagus nerve (NVN), the lateral cuneate nucleus 
(LCN), the nucleus of the trigeminal nerve spinal tract (NTN), and the olivary nucleus (ON). Black bars: control 
sheep, grey bars: scrapie-infected sheep. The differences between the two experimental groups were determined 
using the Mann Whitney U test (*P < 0.05 and **P < 0.01).
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Figure 3. Immunostaining patterns of ATG5 protein in different CNS regions. (A) Strong immunostaining 
in cerebellum from control animals (50 µm). (B) Similar immunostaining in cerebellum from scrapie sheep, 
note the perineuronal arrangement around the Purkinje cells (arrows). No differences were observed between 
groups (50 µm). (C) Lack of intraneuronal staining in pons from control sheep (100 µm). (D) Intracytoplasmic 
immunolabelling of several neurons in pons of scrapie animals. Due to a high variability observed within these 
animals, this tissue did not show significant differences (50 µm). (E) Absence of immunostaining in the nucleus 
of the trigeminal nerve spinal tract (NTN) from control group (50 µm). (F) Diffuse punctiform immunostaining 
throughout the neuropil and intracytoplasmic immunolabelling of vacuolized and non-vacuolized neurons 
(arrows) in the NTN in the infected sheep (50 µm). In the thalamus, moderate or weak staining was observed 
from both control (G) (50 µm) and scrapie sheep (H) (50 µm) with no significant differences between groups. 
Detail of a neuron (H) (10 µm): ATG5 was occasionally localized in granules within the cytoplasm of some 
neurons, which displayed a perineuronal arrangement.
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neurons and glial cells showing a strong intracytoplasmic immunolabelling and a diffuse punctiform immu-
nostaining throughout the neuropil was observed. There were no significant differences in the remaining tis-
sues between control and scrapie-infected animals. The increment of this marker in cerebella was also validated 
by Western blot, showing a significant increase (P < 0.001) of LC3-A signal in scrapie tissues (Supplementary 
Fig. S4). Similar to LC3-B, LC3-II band was not observed in the immunoblot.
Generalized p62 accumulation in scrapie brains. Accumulation of p62 is commonly used to monitor 
autophagy impairment28. To investigate a possible arrest of autophagy in scrapie, we determined p62 by IHC. 
First, Western blot detected an expected band of ~62 kDa (Supplementary Fig. S3). Immunolabelling for p62 was 
remarkably intense in scrapie-infected animals, whereas little staining was detected in the control group. Scrapie 
sheep displayed significantly higher scores for p62 protein in all CNS areas analysed, although in Bgc this did not 
Figure 4. Immunostaining patterns of LC3-B protein in different CNS regions. (A) Weak immunostaining in 
the cerebellum of a non-infected control animal (100 µm). (B) Intense immunostaining in the cerebellum of a 
scrapie-infected sheep. In the cerebellar cortex, the Purkinje cells were strongly stained and their neurites were 
observed with intense immunolabelling (arrows) (100 µm). (A,B) Detail of LC3-B stained Purkinje cells.  
(C) Absent immunostaining in the basal ganglia from control group (50 µm). (D) Moderate immunostaining  
in the basal ganglia from scrapie animals. Unstained neurons were also observed. Note the nucleus was strongly 
stained (arrows) (50 µm). (E) Strong staining in the Dorsal nucleus of the vagus nerve (NVN) from control 
group (100 µm). (F) Similar immunostaining in the NVN from scrapie-infected sheep. The nucleus was also 
positive in neurons with unstained cytoplasm (arrows) (100 µm).
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reach significance (Fig. 2G). Moreover, all Mo nuclei showed significant increases of this protein in the scrapie 
group (Fig. 2H). Staining for p62 presented a strong and coarse granular pattern within the cytoplasm of cells, and 
occasionally in the neuropil, in Fc, Bg, Bgc and Tc (Fig. 6). In the remaining tissues, p62 was characterised by a 
moderate punctiform pattern in the neuropil in healthy sheep, and by an intense granular immunolabelling of the 
neuropil and a uniform intracytoplasmic staining of both neurons and glial cells in scrapie animals.
Association between ATG5 and LC3 proteins and histological features of scrapie. Protein scores 
for ATG5, LC3-A and LC3-B displayed positive Spearman correlations (Table 1), confirming the association 
detected between ATG5 and LC3-B gene expression data (see above). However, in contrast to the RNA expression, 
LC3 proteins positively correlated with prion deposition and neuropil spongiosis both in the total set of animals 
Figure 5. Immunostaining patterns of LC3-A protein in different CNS regions. (A) Moderate or weak 
immunostaining in the cerebellum from control animals (100 µm). (B) Intense immunostaining in the 
cerebellum from scrapie-infected sheep. In the molecular layer of the cerebellar cortex, a strong signal was 
observed in the Purkinje cells and their neurites (arrows) (100 µm). (C) Absent immunostaining in the pons 
from control group (100 µm). (D) In the pons of scrapie animals, some specific neural populations were 
strongly immunolabelled. Spotted and punctiform pattern was observed in the neuropil. Note the cytoplasmic 
immunostaining in vacuolized and non-vacuolized neurons (arrows) (100 µm). (E) Absent immunostaining in 
the hypoglossal motor nucleus (HMN) from control group (100 µm). (F) Diffuse punctiform immunostaining 
throughout the neuropil and intracytoplasmic immunolabelling of several neurons in the HMN in infected 
sheep (50 µm). (A,B and F) Detail of LC3-A stained neurons.
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Figure 6. Immunostaining patterns of p62 protein in different CNS regions. (A) Weak granular pattern 
in the neuropil of basal ganglia of a non-infected control animal (50 µm). (B) Strong and coarse granular 
immunostaining in the neuropil and within the cytoplasm of cells in basal ganglia of a scrapie-infected 
sheep (50 µm). (C) Predominantly mild neuropil punctiform pattern in pons from control group sheep brain 
(100 µm). (D) Intense granular immunolabelling of the neuropil and intracytoplasmic staining of both neurons 
and glial cells in pons in scrapie-infected sheep (100 µm). (E) Weak punctiform staining in cerebellum in 
healthy sheep (50 µm). (F) Strong granular pattern and uniform intracytoplasmic staining of cells in cerebellum 
in scrapie-infected sheep (50 µm). (G) Moderate punctiform immunostaining of the neuropil in the dorsal 
nucleus of the vagus nerve (NVN) from control group (100 µm). (H) Intense staining of the neuropil and cells in 
the NVN in scrapie animals (100 µm). (B,D,F and H) An intense immunolabelling of cells whose morphology 
is compatible with glial cells (arrows and detail) was observed in scrapie-infected sheep. (E,F,G and H) Detail of 
p62 stained neurons.
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and in the scrapie group (Table 1), suggesting that these proteins accumulate as the lesions related to the disease 
become more evident.
p62 distribution is not related with prion deposition but with spongiform degeneration. As 
shown previously, p62 was overexpressed in almost all analysed areas. Besides that, p62 and LC3-B immunostain-
ing correlated in the total set of animals (Spearman ρ = 0.440, P < 0.001) and the association was even stronger in 
scrapie sheep (Spearman ρ = 0.632, P < 0.001) (Table 1). As the intensity of immunostaining was not the same in 
the different tissues, this correlation suggests that the areas where p62 accumulates in a higher degree are the same 
as those where LC3-B is also strongly concentrated. Finally, p62 did not correlate with PrPSc deposition or neu-
ronal vacuolation but displayed a relatively strong correlation with neuropil spongiosis in all animals (Spearman 
ρ = 0.756, P < 0.001) and weaker correlation within scrapie animals (Spearman ρ = 0.344, P < 0.05).
Autophagy markers in cerebellar Purkinje cells. Three out of the four autophagy markers analysed 
by IHC displayed a significantly higher scores in scrapie cerebella and this increment seemed to be mainly due 
to the differences observed in immunostaining of Purkinje cells. To verify these observations quantitatively, we 
determined the number of stained and unstained cells in 5 independent fields for each animal. For LC3-B (Fig. 4) 
and LC3-A (Fig. 5), the Purkinje cells were strongly stained, and their neurites were occasionally observed with 
intense cytoplasmic immunolabelling. Although the percentage of stained Purkinje cells for LC3-B appeared 
to be higher in scrapie animals (82.0% ± 13.1) compared to controls (65.1 ± 30.5), these differences were not 
statistically significant. However, LC3-A was statistically increased in scrapie sheep where 94.7% ± 14.6% of the 
cells were positive for LC3-A compared with 68.8 ± 31.2% in controls (P < 0.01). Finally, Purkinje cells showed a 
moderate intraneuronal punctiform staining for p62 (Fig. 6) and the number of stained cells was greatly increased 
(P < 0.001) in scrapie animals (88.5 ± 20.3%) compared with controls (21.2 ± 14.5%). The graph of these results 
is shown in Supplementary Fig. S4.
Discussion
Prion diseases are a group of neurodegenerative disorders characterized by accumulation of a proteinase resist-
ant form of the prion protein (PrPSc) in the CNS, which leads to spongiform degeneration and ultimate neu-
ronal death. This process may involve several cellular pathways, including apoptosis and autophagy7. In previous 
studies assessing the molecular mechanisms of apoptosis in the CNS of sheep naturally infected with scrapie8,9, 
the induction of apoptotic pathways in scrapie brains was described29. However, there was no convincing evi-
dence of a massive neuronal apoptosis, suggesting a possible activation of neuroprotective mechanisms. The 
aim of the present work was to analyse alterations in one of these mechanisms, autophagy, in scrapie-related 
neurodegeneration.
Basal levels of autophagy are important to maintain normal cellular homeostasis. However, unregulated deg-
radation of the cytoplasmic components is likely to be deleterious. Although the CNS presents only low levels of 
autophagosomes under normal conditions, autophagy plays a critical role in the constitutive turnover of cytosolic 
contents and the removal of damaged proteins in specific neurons of the brain30. Defects in autophagy could 
impair the quality control of proteins, leading to the accumulation of toxic aggregates and subsequently, to neu-
rodegeneration. In accordance, the presence of abnormal autophagic activity is frequently observed in neurode-
generative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis30,31. Despite the 
increase in autophagosomes detected in degenerating neurons30,31, it is still not clear how the autophagic machin-
ery is involved during the pathogenic course of these diseases.
Autophagic vacuoles associated with prion diseases have been described in experimental models such as mice 
and hamsters infected with prions15,16,21. These vacuoles and multi-vesicular bodies also appear in prion-infected 
cultured neuronal cells32 and in brain biopsy materials of prion-infected patients7,17. Combining two different 
methodologies, qRT-PCR and IHC, we have investigated the dynamics of autophagy in scrapie-induced neuro-




vacuolation PrPSc ATG5 LC3-A LC3-B
ATG5 0.271** 0.446*** 0.287** — 0.375** 0.422***
All animals
LC3-A 0.397* 0.315* 0.373** 0.375** — 0.330**
LC3-B 0.332*** N.S. 0.389*** 0.422*** 0.330** —
p62 0.756*** 0.478*** 0.780*** N.S. N.S. 0.440***
ATG5 0.651*** 0.571*** 0.577*** — 0.487** 0.365*
Scrapie sheep
LC3-A 0.397* N.S. 0.409** 0.487** — 0.381*
LC3-B 0.429** N.S. 0.332* 0.365* 0.381* —
p62 0.344* N.S. N.S. N.S. N.S. 0.632***
Table 1. Spearman correlation values between histological features (spongiosis, intraneuronal vacuolation 
and PrPSc, ATG5, LC3-A, LC3-B and p62 immunostaining) in the total set of animals and in scrapie infected 
animals. Correlations were estimated using the full set of data obtained in all tissues. No statistically significant 
correlation values are shown as N.S. (*P < 0.05, **P < 0.01; ***P < 0.001).
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We carried out a first gene expression analysis of ATG5, BECN1, ATG9 and LC3-B in naturally scrapie-infected 
sheep brains. ATG5 and ATG9 participate in the elongation33 and closing34 of the pre-autophagosomal mem-
brane, respectively, although neither of these proteins will be present in mature autophagosomes. BECN1, on the 
other hand, plays a central role in coordinating the cytoprotective function of autophagy, and regulates apoptosis 
and other cellular processes35. Four different genes encode LC3s proteins36, of which LC3-B protein has been most 
widely used for tracking autophagy. LC3 proteins are expressed in most cell types as the cytosolic protein form 
LC3-I that, upon induction of autophagy, is conjugated to phosphatidylethanolamine to form LC3-II, a lipidated 
form associated with autophagic membranes37. Because LC3-II is a structural component of mature autopha-
gosomes, this protein is commonly used as a specific marker for autophagy38. Finally, p62/SQSTM1 is a cargo 
receptor that acts as a substrate during autophagic degradation, which causes this protein to be degraded by auto-
phagosomes39. Therefore, the evaluation of p62 accumulation may be used to estimate autophagic impairment28.
Downregulation of autophagy genes beclin-1 and Atg5 was previously described in whole brain tissues of 
prion-infected wild-type mice40. Here, transcript expression levels of genes ATG5 and ATG9 decreased signif-
icantly in thalamus and cerebellum, respectively, of scrapie-infected sheep, and BECN1 expression displayed a 
negative correlation with prion deposition in scrapie thalamus. Since autophagy is involved in the turnover of 
proteins through lysosomal degradation, this process seems to be protective in various neurodegenerative pro-
cesses, including prion diseases30,41. In this context, the downregulation of autophagy genes upon prion infection 
would suggest autophagy decrease, which would contribute to the accumulation of PrPSc aggregates and its con-
sequent toxicity.
Immunohistochemical tools can be used to identify groups of cells or specific CNS regions were autophagy 
is altered. Contrary to the downregulation of ATG5 protein described in brains from murine models of sporadic 
CJD (sCJD)18, ATG5 expression scores in natural scrapie correlated positively with the amount of PrPSc deposits. 
Moreover, in contrast to its reduced transcript levels, ATG5 protein increased in one of the most affected areas 
of the CNS of scrapie-infected animals, the nucleus of the trigeminal nerve spinal tract of medulla oblongata. 
Occasionally, this protein also displayed a perineuronal arrangement within the neuronal cytoplasm. Although 
the subcellular localization of ATG5 is still not clear, it binds membranes and is essential for autophagy and 
cytoplasm-to-vacuole transport42. Therefore, the observed perineuronal localization of ATG5 may indicate the 
induction of autophagosome formation in these neurons. However, the retrograde transport of autophagosomes 
and their maturation to lysosomes are impaired in other neurodegenerative diseases such as Alzheimer’s disease, 
which results in a massive accumulation of autophagic vacuoles within degenerating neurites43. In this case, the 
combination of increased autophagy induction and defective clearance results in Aβ accumulation44. It is plausi-
ble that increased ATG5 immunostaining observed here in highly affected areas in scrapie brains could reflect the 
induction and subsequent accumulation of non-functional autophagosomes in neurites, which may contribute 
to the development of prion disease. This accumulation could also explain the negative correlation observed 
between the levels of RNA and protein expression as increased autophagic proteins could lead to downregulation 
of their gene expression directly or indirectly through negative feedback.
Although LC3-B has been the most studied LC3 form to monitor autophagy38,45,46, different subcellular dis-
tribution for LC3 proteins has been previously described in human cancer cell lines and it was suggested that 
autophagosomes are formed by only one of the LC3 proteins47. In accordance, these proteins differ somewhat 
in their distribution and immunohistochemical patterns in scrapie brains and it was LC3-A which showed most 
significant increases. Besides in the neuronal cytoplasm, LC3-B immunostaining was also positive in the nucleus, 
probably because of its abundant nuclear presence48. LC3 becomes selectively activated in the nucleus during 
starvation to be subsequently redistributed to cytoplasm, where it plays a central role in autophagy49. Although 
IHC does not allow the discrimination between LC3-I and LC3-II forms, a punctate pattern similar to the one 
observed in our work has been related with the presence of autophagosomes50.
As we have discussed above, autophagy impairment has been propose as a pathogenic mechanism in 
Alzheimer’s disease patients and murine models of sCJD where the expression of ATG proteins is reduced, while 
the level of LC3-II, the main autophagosomal marker, is increased18,51,52. In our study, immunostaining of LC3s 
proteins displayed a positive correlation with prion deposition and neuropil spongiosis. However, whereas LC3-A 
was significantly increased in both highly affected areas (medulla oblongata and pons) and cell populations with 
a lower degree of lesion (cerebellar Purkinje cells), LC3-B seemed to be slightly increased in most of the areas 
analysed in scrapie brains but was significantly upregulated only in two of the less affected areas, cerebellum and 
basal ganglia. Thus, the levels of these LC3s proteins as such do not reflect scrapie neuropathology in a simple 
manner but seem to respond differently, possibly depending on the disease stage.
The accumulation of p62 in cells and tissues from autophagy-deficient mice53 indicated that the degradation 
of p62 is dependent on autophagy. In prion research, some in vitro studies have proposed the enhancement of 
p62-activity as a possible therapeutic target for the induction of autophagy, because overexpression of p62 pro-
motes degradation of PrPSc 54. However, the accumulation of p62 is generally used as a marker for inhibition or 
defects in autophagic activity55. Contrary to p62 downregulation observed in hamsters infected with prions20, 
p62 accumulates in scrapie brains in almost all CNS areas analysed, which would indicate an impairment of auto-
phagic activity in the CNS during the course of the natural disease. In the same manner, the amino-terminally 
truncated prion protein PrP90-231 triggers autophagic process through the upregulation of both LC3-II and p62 
in vitro, leading to progressive accumulation of autophagolysosomes with impaired resolution ability, resulting in 
prion accumulation and toxicity23.
In scrapie brains, p62 was generally increased but its immunostaining did not correlate with PrPSc deposition, 
as it was upregulated in areas with different degrees of lesions. The increment of p62 is normally associated to 
a reduction of autophagy, however, the increment of LC3 and p62 simultaneously has been also linked with an 
increment of autophagy54, making interpretation of results difficult. On one hand, upregulation of p62 and ATG5 
in highly affected areas (medulla oblongata) could reflect an unsuccessful effort of the neurons for counteracting 
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prion infection leading to autophagy impairment and the accumulation of non-functional autophagosomes. On 
the other hand, overexpression of LC3s and p62 proteins, but not ATG5, in minimally prion-affected areas of 
scrapie-infected animals (cerebellum and basal ganglia) suggests the activation of the autophagic machinery as a 
defence mechanism that protects against neurodegeneration and leads to prion clearance, as it has been proposed 
in murine models in vivo54, but it could also reflect a very early moment in autophagy impairment.
Moreover, in Purkinje cells of scrapie animals there was an overrepresentation of LC3-A and p62 positive 
stained cells compared to controls. In these cells, ATG5 remained unchanged and p62 staining was lower than 
in highly affected areas. This could indicate successful induction of autophagy in these cells. These results are in 
accordance with previous studies that indicate a remarkably efficient autophagosome formation in Purkinje cells 
of hamsters inoculated with 263K scrapie agent20. A previous study revealed intense immunolabelling of chap-
erones Hsp70 and Hsp90 in Purkinje cells of natural scrapie sheep56. Chaperones, like autophagy, are involved in 
the removing of altered proteins from the cell. Hence, both processes may be interwoven and involved in specific 
neuroprotective mechanisms in this cell type against the toxicity of PrPSc. However, we cannot rule out that the 
changes observed constitute an early mechanism in the response to prion toxicity as cerebellum is one of the tis-
sues that is affected later in classical scrapie. The analysis of atypical scrapie cases where PrPSc immunolabelling is 
particularly prominent in the cerebellum57 would contribute to clarify the role of autophagy in these cells.
To conclude, the presented gene expression and immunohistochemical study suggests a differential regula-
tion of autophagic machinery in the different areas of the CNS in scrapie infected sheep used as a natural model 
of prion diseases. The downregulation of autophagy related genes and the increment of ATG5 and p62 suggest 
an arrest of the autophagy machinery in highly affected areas that could be a consequence of an impairment of 
neuronal function and would facilitate prion replication. Conversely, specific areas and cell populations like basal 
ganglia and cerebellar Purkinje cells could still have the autophagy machinery intact and the overexpression of 
LC3-A and p62 would facilitate prion elimination and cell survival. The impairment of autophagy could be a late 
effect of the disease and it should be considered when designing possible treatments directed to induce autophagy.
Methods
Animals and sample collection. In this work, 12 female sheep (Rasa Aragonesa breed), including six 
controls and six animals naturally infected with scrapie, were used. Scrapie infected animals were adults of age 
56.30 ± 5.76 months, and displayed the ARQ/ARQ genotype for PRNP (prion protein) gene (homozygous for 
polymorphism at codons 136, 154 and 171), which is the most frequently observed genotype in scrapie animals 
from this breed58. These animals came from scrapie-infected flocks from several geographical regions and were 
diagnosed in vivo by the clinical signs associated with the disease. To confirm the diagnosis of scrapie post-mor-
tem, we used IHC to detect PrPSc in the medulla oblongata with the L42 monoclonal antibody, as described in 
the “Histopathological and PrPSc detection studies” section below. Control animals (n = 6) of the same genotype, 
breed, sex, and similar age (48.81 ± 16.93 months) were selected from flocks belonging to scrapie-free regions. To 
reveal any additional polymorphisms in the PRNP gene, we sequenced the coding region from the experimental 
sheep following the previously described methods59. Supplementary Table S3 shows detailed characteristics of 
the experimental animals. Protective polymorphism at codon 14160 was observed in one control sheep. Variation 
in codon 143 displayed heterozygous and homozygous genotypes for the rare variant 143R in two control sheep. 
Finally, dimorphism at codon 176 was detected in other control sheep. Scrapie infected sheep did not display 
additional polymorphisms.
Animals were sacrificed by intravenous injection of sodium pentobarbital and exsanguination, with subse-
quent necropsy. Post-mortem examination of the animals did not reveal any additional pathologies. Sample col-
lection followed the established safety guidelines. Immediately after extraction, the whole brain was divided into 
two sagittal halves. One of these halves was fixed in 10% neutral-buffered formalin for histopathological and 
immunohistochemical analysis and the other one was immediately frozen on dry ice and maintained at −80 °C 
temperature until RNA extraction for gene expression studies. Later, the brains were dissected in five sections 
to isolate the most relevant neuropathological tissues, i.e. Fc, Bg along with Bgc, T with Tc, P with Cbl, and Mo.
Histopathological and PrPsc detection studies. Brain slices (2–3 mm) were paraffin-embedded 
and intraneuronal vacuolation and neuropil spongiosis were evaluated in 4 µm sections stained with 
haematoxylin-eosin (HE) in eight brain areas (Fc, Bg, Bgc, T, Tc, P, Cbl and Mo) and five neuronal nuclei of 
the Mo. IHC for PrPSc detection in the selected regions was performed as previously described61 using the 
mouse monoclonal antibody L42 [1:500 dilution at RT (room temperature) for 30 minutes (min); R-Biopharm, 
Darmstadt, Germany] as the primary antibody.
Gene expression. To analyse the expression of ATG5, BECN1, ATG9 and LC3-B genes by qRT-PCR, total 
RNA was isolated from Fc, T, Cbl, and Mo using the RNeasy Lipid Tissue Mini Kit (Qiagen, Crawley, UK) accord-
ing to the manufacturer’s instructions. Tissue samples were homogenised using a TeSeE Precess 48 (Bio-Rad, CA, 
USA) and TURBO DNase (Ambion, Austin, TX, USA) was used to remove possible genomic DNA contamina-
tion. Complementary DNA (cDNA) was synthesized from 1 µg of total RNA using random hexamers with the 
Superscript First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA, USA).
Supplementary Table S4 shows the specific primers for the genes of interest used for qRT-PCR. In order to 
improve the accuracy of normalization we used the geometric mean of the expression of three housekeeping 
genes (GAPDH, G6PDH and RPL32) in the same sample as normalization factor. These housekeeping genes 
are the three most stably expressed reference genes in sheep brain62. Their use as internal references in previous 
expression studies concerning scrapie infection and the primers and PCR conditions used for their amplification 
have been previously described62.
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PCR amplifications were performed in a 7500 Fast Real-Time PCR System (PE Applied Biosystems) using 
SYBR® Green (PE Applied Biosystems) assays. All qRT-PCR reactions were run in triplicate in a total reaction 
volume of 10 µl using cDNA equivalent to 10–20 ng total RNA as template. Universal amplification conditions 
were used, with an initial activation and cDNA denaturation step for 10 min at 95 °C, followed by 40 cycles of 
3 seconds (s) at 95 °C and 30 s at 60 °C. To identify the presence of nonspecific PCR amplicons or high levels 
of primer dimers, we performed a dissociation curve protocol after each qRT-PCR reaction. The levels of gene 
expression were determined using the comparative Ct method. The Ct calculations were set automatically with 
the ABI-Prism 7500 software, version 2.0.1.
Immunohistochemical determination of autophagy markers. The expression and distribution of 
ATG5, LC3s and p62 proteins were studied by IHC in formalin-fixed, paraffin-embedded CNS tissue sections 
from the clinical scrapie sheep and control animals. The tissues were pre-treated using heat-induced epitope 
retrieval with Tris EDTA buffer (pH 9.0) in a PTLink (Dako) at 96 °C for 20 min. Sections were incubated at 
4 °C overnight for mouse monoclonal anti APG5 (C-1, sc-133158; Santa Cruz Biotechnology, 1:50) and rabbit 
polyclonal anti MAP-LC3α (R-23, sc-134226; Santa Cruz Biotechnology, 1:50), and 1 hour (h) at RT for mouse 
monoclonal anti MAP-LC3β (G-2, sc-271625; Santa Cruz Biotechnology, 1:200) and rabbit polyclonal anti p62 
(PW9860; Enzo Life Sciences, 1:200). Omission of the primary antibody served as background control for non-
specific staining. The visualization system used was the enzyme-conjugated polymer EnVision (Dako EnVision 
anti-mouse for APG5 and MAP-LC3β; Dako EnVision anti-rabbit for MAP-LC3α and p62).
Western blot determination of autophagy markers. Before IHC, the specificity of antibodies against 
ATG5, LC3-B, LC3-A and p62 was prior determined by Western blot (Supplementary Fig. S3). At least 0.5 g of 
the CNS tissues (Fc, T, Cbl and Mo) were homogenized each in 5 ml of Prionics® Check Western homogenization 
buffer (Prionics AG, Zurich, Switzerland) and centrifuged twice at 10000 × g for 10 min at 4 °C. The supernatants 
were analysed by Western blot. Briefly, 25 μg of total protein was subjected to 10% SDS/PAGE and transferred 
to PVDF membranes (GE Healthcare, UK). After blocking at 4 °C overnight, the membranes were incubated 
for 1 h at RT with the above described primary antibodies diluted in blocking buffer: anti APG5 (1:1000 dilu-
tion); anti MAP-LC3β (1:8000); anti MAP-LC3α (1:1000), and anti p62 (1:1000). In addition, goat polyclonal 
anti Actin (I-19, sc-1616; Santa Cruz Biotechnology, 1:10000) was used to normalize results. Next, the mem-
branes were incubated for 1 h at RT with a HRP-conjugated secondary antibody diluted 1:4000 in blocking buffer 
(goat anti-mouse IgG-HRP for APG5 and MAP-LC3β, or goat anti-rabbit IgG-HRP for MAP-LC3α and p62; 
Santa Cruz Biotechnology, CA, USA). After washing, Western blots were developed using the ECL Plus Western 
Blotting system (GE Healthcare, UK) and visualized with VersaDoc imaging system (Bio-Rad).
In order to verify the differences observed by IHC for LC3-A and LC3-B and to visualize LC3-I and LC3-II 
bands, we compared lysates from scrapie (n = 4) and control (n = 4) cerebella. The quantification analysis was 
performed based on the blotting results using the ImageJ 1.4.3.67 image-analysis software package (Psion Image, 
NIH) following a simple method of analysis, performed by integrating the grey levels of pixels (volume) sur-
rounded by a rectangular selection. This method is described on the ImageJ website63. Density of immunoreactive 
bands for autophagy markers was normalized for Actin density band and is reported as arbitrary units (a.u.). Data 
are expressed as means ± standard error.
Data analysis. The tissue sections were examined with a ZEISS Axioskop 40 optical microscope. The extent 
of neuronal vacuolation, neuropil spongiosis, PrPSc deposition, as well as ATG5, LC3s and p62 immunolabelling 
was evaluated semi-quantitatively and scored on a scale ranging from 0 to 5 (0 = absence of lesions or immuno-
labelling, 5 = substantial lesions or immunolabelling throughout the region) as previously described64–66. Scoring 
for each parameter (either a lesion type or an immunolabelling pattern) of each studied area was blind performed 
by a pathologist making subjective evaluation. Scores for each specific area are plotted as the mean ± stand-
ard error of all individuals in each group. Histopathological and immunohistochemical differences between the 
experimental groups were evaluated using non-parametric Mann Whitney U test.
Relative gene expression values were log transformed and data were analysed with the Student’s t-test. 
Similarly, normalized protein expression values obtained by Western blot were compared with the Student’s t-test. 
Moreover, correlations between gene expression, protein immunolabelling and the different lesions were deter-
mined using the non-parametric Spearman’s rank correlation coefficient (rho, ρ). In all tests, the results were 
considered significant at P < 0.05. We used IBM® SPSS® statistics 22 software for all data analysis. Finally, to iden-
tify possible differences in LC3-B, LC3-A and p62 immunolabelling in Purkinje cells, stained and non-stained 
Purkinje cells were counted in five microscope areas (20× magnification) for each animal. Proportions were 
converted to arcsine values before applying the Student’s t-test.
Ethics approval. The Ethics Committee for Animal Experiments of the University of Zaragoza (Permit 
Number: PI38/15) approved all procedures. The care and use of experimental animals were performed in strict 
accordance with the national law (R.D. 53/2013).
Data Availability
Row data from qPCR and IHC scoring are available from authors upon request.
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